Perioperative outcomes and prospective patient reported outcome measures for transvaginal mesh surgery

Abstract

Our data revealed a very low intraoperative complication rate with a mesh exposure rate of 4 %. The prospective study showed a statistically significant improvement in vaginal symptoms.

Prospective long-term results, complications and risk factors in pelvic organ prolapse treatment with vaginal mesh

“…There is little data concerning defecation situation after POP surgery with meshes. Some studies reported less constipation than before [17]. Unlike them, we found a worsening of this symptom in our patients, which was statistically significant, although there were some of them in whom it improved.…”

“…In October 2008, the FDA responded to the emerging complications related to the meshes, followed by an updated safety communication in July 2011. However, there are currently scarce data with regard to long-term results and complications [16,17]. The majority of studies published are retrospective [13,14,18], and those which are prospective have a short or medium follow-up.…”

“…Late complications included mesh extrusion, mesh retraction, de novo pain, de novo dyspareunia, vesicovaginal fistula, rectovaginal fistula, abscess and vaginal discomfort [17,[22][23][24][25]28]. The most common complication was the extrusion of the mesh, constituting up to 40% of them.…”

Assessing the use of the IUGA/ICS classification system for prosthesis/graft complications in publications from 2011 to 2015

“…There was no consistent method of presenting the assigned CTS codes. Some reported summaries or general descriptions of assigned codes [3,16,21,25], whereas others specified both the unique CTS codes and the number of patients assigned codes [2,4,5,14,15,[17][18][19][20][22][23][24]. One publication assigned codes to the cohort upon initial presentation and again following prosthesis/graft removal [5].…”

Safety and Effectiveness of Transvaginal Mesh Placement in Treating Pelvic Organ Prolapse

“…Mesh exposure and invasion are the most common complications after TVM placement. According to previous literature report, the mesh exposure rate ranges from 1.4% to 36% 18,19,21,22 , while in the Cochrane review 1 , the mesh exposure rate is 12%, and 8% patients require further surgical treatment. In our study, only 2 (2.2%) patients had asymptomatic recurrence during postoperative follow-up ,but no further treatment was selected owing to little impact on quality of life.…”